Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous System-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous System

Published:2011-04 Issue:5 Volume:79 Page:1487-1495
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Levin Victor A.,Bidaut Luc,Hou Ping,Kumar Ashok J.,Wefel Jeffrey S.,Bekele B. Nebiyou,Prabhu Sujit,Loghin Monica,Gilbert Mark R.,Jackson Edward F.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference28 articles.

1. Impact of radionecrosis on cognitive dysfunction in patients after radiotherapy for nasopharyngeal carcinoma;Cheung;Cancer,2003

2. Cerebral radiation necrosis;Giglio;Neurology,2003

3. Neurobehavioral sequelae of cranial irradiation in adults: A review of radiation-induced encephalopathy;Crossen;J Clin Oncol,1994

4. Tolerance of the brain and spinal cord to conventional irradiation;Leibel,1991

5. Neoplasms of the central nervous system;Levin,2001

Cited by 600 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determinants of cerebral radionecrosis in animal models: A systematic review;Radiotherapy and Oncology;2024-10

2. Re-irradiation treatment regimens for patients with recurrent glioma – Evaluation of the optimal dose and best concurrent therapy;Radiotherapy and Oncology;2024-10

3. Medical and neurologic management of brain tumor patients;Current Opinion in Neurology;2024-09-03

4. Bevacizumab reduces cerebral radiation necrosis due to stereotactic radiotherapy in non-small cell lung cancer patients with brain metastases: an inverse probability of treatment weighting analysis;Frontiers in Immunology;2024-08-27

5. A bibliometric analysis of radiation-induced brain injury: a research of the literature from 1998 to 2023;Discover Oncology;2024-08-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3